Tag Archives: pharmaceutical funding
Marc-André Gagnon urges modernization and fairness in the pricing of patented drugs in Canada
Matthew Herder argues that recent drug price hikes are only one part of a bigger problem with industry-driven pharmaceutical research and development.
Abby Lippman, Alana Cattapan, and Kelly Holloway argue for rigorous, conflict-free research into the safety and effectiveness of the HPV vaccine and for a critical approach to its use.
Nicholas G. Evans makes the distinction between being partial and being compromised.
Kelly Hills joins the conversation on money, power, responsibility and accountability in bioethics and denounces corporate funding of bioethicists.
Alice Dreger underscores the split in Bioethics being debated at Impact Ethics with the latest news from the SUPPORT trial controversy.
Carl Elliott responds to Rob MacDougall: The goal is not to achieve perfect impartiality.